Wang D, Lippard SJ. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov. 2005;4:307–20.
Article
CAS
PubMed
Google Scholar
Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 2003;22:7265–79.
Article
CAS
PubMed
Google Scholar
Muggia FM, Los G. Platinum resistance: laboratory findings and clinical implications. Stem Cells. 1993;11:182–93.
Article
CAS
PubMed
Google Scholar
Wu YJ, Muldoon LL, Neuwelt EA. The Chemoprotective Agent N-Acetylcysteine Blocks Cisplatin-Induced Apoptosis through Caspase Signaling Pathway. J Pharmacol Exp Ther. 2005;312:424–31.
Article
CAS
PubMed
Google Scholar
Al-Eisawi Z, Beale P, Chan C, Yu JQ, Huq F. Modulation of Cisplatin Cytotoxicity due to its Combination with Bortezomib and the Nature of its Administration. Anticancer Res. 2011;31:2757–62.
CAS
PubMed
Google Scholar
Dhara SC. Rapid method for the synthesis of cis[Pt(NH3)2Cl2]. Indian J Chem. 1970;8:193–4.
Google Scholar
Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63.
Article
CAS
PubMed
Google Scholar
Chou TC. Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method. Cancer Res. 2010;70:440–6.
Article
CAS
PubMed
Google Scholar
Chou TC. Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies. Pharmacol Rev. 2006;58:621–81.
Article
CAS
PubMed
Google Scholar
Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 1984;22:27–55.
Article
CAS
PubMed
Google Scholar
Al-Eisawi Z, Beale P, Chan C, Yu J, Huq F. Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models. J Ovarian Res. 2013;6:78.
Article
PubMed
PubMed Central
CAS
Google Scholar
Bowtell DDL. Rapid isolation of eukaryotic DNA. Anal Biochem. 1987;162:463–5.
Article
CAS
PubMed
Google Scholar
Balendiran GK, Dabur R, Fraser D. The role of glutathione in cancer. Cell Biochem Funct. 2004;22:343–52.
Article
CAS
PubMed
Google Scholar
Godwin AK, Meister A, O’Dwyer PJ, Huang CS, Hamilton TC, Anderson ME. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci. 1992;89:3070–4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rabik CA, Dolan ME. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev. 2007;33:9–23.
Article
CAS
PubMed
Google Scholar
Sharma S, Gong P, Temple B, Bhattacharyya D, Dokholyan NV, Chaney SG. Molecular Dynamic Simulations of Cisplatin- and Oxaliplatin-d(GG) Intrastand Cross-links Reveal Differences in their Conformational Dynamics. J Mol Biol. 2007;373:1123–40.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wu Y, Bhattacharyya D, King CL, Baskerville-Abraham I, Huh SH, Boysen G, et al. Solution Structures of a DNA Dodecamer Duplex with and without a Cisplatin 1,2-d(GG) Intrastrand Cross-Link: Comparison with the Same DNA Duplex Containing an Oxaliplatin 1,2-d(GG) Intrastrand Cross-Link. Biochemistry (Mosc). 2007;46:6477–87.
Article
CAS
Google Scholar
Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature. 2000;408:307–10.
Article
CAS
PubMed
Google Scholar
Yuan Z, Cao K, Lin C, Li L, Liu HY, Zhao XY, et al. The p53 upregulated modulator of apoptosis (PUMA) chemosensitizes intrinsically resistant ovarian cancer cells to cisplatin by lowering the threshold set by Bcl-xL and Mcl-1. Mol Med. 2011;17:1262–74.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kelland LR, Farrell NP. Platinum-Based Drugs in Cancer Therapy. 1st ed. New Jersey: Humana Press; 2000.
Book
Google Scholar
Yachnin JR, Wallin I, Lewensohn R, Sirzén F, Ehrsson H. The kinetics and cytotoxicity of cisplatin and its monohydrated complex. Cancer Lett. 1998;132:175–80.
Article
CAS
PubMed
Google Scholar
Zisowsky J, Koegel S, Leyers S, Devarakonda K, Kassack MU, Osmak M, et al. Relevance of drug uptake and efflux for cisplatin sensitivity of tumor cells. Biochem Pharmacol. 2007;73:298–307.
Article
CAS
PubMed
Google Scholar
Zhang S, Lovejoy KS, Shima JE, Lagpacan LL, Shu Y, Lapuk A, et al. Organic Cation Transporters Are Determinants of Oxaliplatin Cytotoxicity. Cancer Res. 2006;66:8847–57.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hagrman D, Goodisman J, Souid A-K. Kinetic Study on the Reactions of Platinum Drugs with Glutathione. J Pharmacol Exp Ther. 2004;308:658–66.
Article
CAS
PubMed
Google Scholar
Michalke B. Platinum speciation used for elucidating activation or inhibition of Pt-containing anti-cancer drugs. J Trace Elem Med Biol. 2010;24:69–77.
Article
CAS
PubMed
Google Scholar
Di Francesco AM, Ruggiero A, Riccardi R. Cellular and molecular aspects of drugs of the future: oxaliplatin. Cell Mol Life Sci. 2002;59:1914–27.
Article
PubMed
Google Scholar
Townsend DM, Marto JA, Deng M, MacDonald TJ, Hanigan MH. High Pressure Liquid Chromatography and Mass Spectrometry Characterization of the Nephrotoxic Biotransformation Products of Cisplatin. Drug Metab Dispos. 2003;31:705–13.
Article
CAS
PubMed
Google Scholar
Cui M, Mester Z. Electrospray ionization mass spectrometry coupled to liquid chromatography for detection of cisplatin and its hydrated complexes. Rapid Commun Mass Spectrom. 2003;17:1517–27.
Article
CAS
PubMed
Google Scholar
Klein JB, Thongboonkerd V. Proteomics in Nephrology. Switzerland: Karger; 2004.
Google Scholar
Fornuskova D, Stiburek L, Wenchich L, Vinsova K, Hansikova H, Zeman J. Novel insights into the assembly and function of human nuclear-encoded cytochrome c oxidase subunits 4, 5a, 6a, 7a and 7b. Biochem J. 2010;428:363–74.
Article
CAS
PubMed
Google Scholar
Nishigaki R, Osaki M, Hiratsuka M, Toda T, Murakami K, Jeang K-T, et al. Proteomic identification of differentially-expressed genes in human gastric carcinomas. Proteomics. 2005;5:3205–13.
Article
CAS
PubMed
Google Scholar
Liu J, Zhan X, Li M, Li G, Zhang P, Xiao Z, et al. Mitochondrial proteomics of nasopharyngeal carcinoma metastasis. BMC Med Genomics. 2012;5:62.
Article
CAS
PubMed
PubMed Central
Google Scholar
Agrawal PB, Joshi M, Savic T, Chen Z, Beggs AH. Normal myofibrillar development followed by progressive sarcomeric disruption with actin accumulations in a mouse Cfl2 knockout demonstrates requirement of cofilin-2 for muscle maintenance. Hum Mol Genet. 2012;21.
Fu H, Subramanian RR, Masters SC. 14-3-3 Proteins: Structure, Function, and Regulation. Annu Rev Pharmacol Toxicol. 2000;40:617–47.
Article
CAS
PubMed
Google Scholar
Wen Y, Eng CH, Schmoranzer J, Cabrera-Poch N, Morris EJS, Chen M, et al. EB1 and APC bind to mDia to stabilize microtubules downstream of Rho and promote cell migration. Nat Cell Biol. 2004;6:820–30.
Article
CAS
PubMed
Google Scholar
Garcia Pedrero JM, Fernandez MP, Morgan RO, Herrero Zapatero A, Gonzalez MV, Suarez Nieto C, et al. Annexin A1 Down-Regulation in Head and Neck Cancer Is Associated with Epithelial Differentiation Status. Am J Pathol. 2004;164:73–9.
Article
PubMed
Google Scholar
Mulla A, Christian HC, Solito E, Mendoza N, Morris JF, Buckingham JC. Expression, subcellular localization and phosphorylation status of annexins 1 and 5 in human pituitary adenomas and a growth hormone-secreting carcinoma. Clin Endocrinol (Oxf). 2004;60:107–19.
Article
CAS
Google Scholar
Fernandez MP, Morgan RO, Fernandez MR, Carcedo MT. The gene encoding human annexin V has a TATA-less promoter with a high G + C content. Gene. 1994;149:253–60.
Article
CAS
PubMed
Google Scholar
Grisendi S, Bernardi R, Rossi M, Cheng K, Khandker L, Manova K, et al. Role of nucleophosmin in embryonic development and tumorigenesis. Nature. 2005;437:147–53.
Article
CAS
PubMed
Google Scholar
Lim MJ, Wang XW. Nucleophosmin and human cancer. Cancer Detect Prev. 2006;30:481–90.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bertwistle D, Sugimoto M, Sherr CJ. Physical and Functional Interactions of the Arf Tumor Suppressor Protein with Nucleophosmin/B23. Mol Cell Biol. 2004;24:985–96.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kurki S, Peltonen K, Latonen L, Kiviharju TM, Ojala PM, Meek D, et al. Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell. 2004;5:465–75.
Article
CAS
PubMed
Google Scholar
Updike MS, Sawdy JC, Wang L-S, Liu S, Huang Y-W, Ye W, et al. Primary cultured human breast epithelial cells up-regulate protein disulfide isomerase in response to zeranol. Anticancer Res. 2007;27:407–10.
CAS
PubMed
Google Scholar
Lee HH, Lim CA, Cheong YT, Singh M, Gam LH. Comparison of Protein Expression Profiles of Different Stages of Lymph Nodes Metastasis in Breast Cancer. Int J Biol Sci. 2012;8:353–62.
Article
CAS
PubMed
PubMed Central
Google Scholar
Leys CM, Nomura S, Lafleur BJ, Ferrone S, Kaminishi M, Montgomery E, et al. Expression and prognostic significance of prothymosin-α and ERp57 in human gastric cancer. Surgery. 2007;141:41–50.
Article
PubMed
Google Scholar
Pressinotti N, Klocker H, Schafer G, Luu V-D, Ruschhaupt M, Kuner R, et al. Differential expression of apoptotic genes PDIA3 and MAP3K5 distinguishes between low- and high-risk prostate cancer. Mol Cancer. 2009;8:130.
Article
PubMed
PubMed Central
CAS
Google Scholar
Garbi N, Tanaka S, Momburg F, Hammerling GJ. Impaired assembly of the major histocompatibility complex class I peptide-loading complex in mice deficient in the oxidoreductase ERp57. Nat Immunol. 2006;7:93–102.
Article
CAS
PubMed
Google Scholar
Chay D, Cho H, Lim BJ, Kang ES, Oh YJ, Choi SM, et al. ER-60 (PDIA3) is highly expressed in a newly established serous ovarian cancer cell line, YDOV-139. Int J Oncol. 2010;37:399–412.
CAS
PubMed
Google Scholar
Graven KK, Molvar C, Roncarati JS, Klahn BD, Lowrey S, Farber HW. Identification of protein disulfide isomerase as an endothelial hypoxic stress protein. Am J Physiol Lung Cell Mol Physiol. 2002;282:L996–L1003.
Article
CAS
PubMed
Google Scholar
Yabe D, Taniwaki M, Nakamura T, Kanazawa N, Tashiro K, Honjo T. Human Calumenin Gene (CALU): cDNA Isolation and Chromosomal Mapping to 7q32. Genomics. 1998;49:331–3.
Article
CAS
PubMed
Google Scholar
Takazawa K, Tsuchiya H, Yoshimichi U, Kanazawa Y, Sadao I, Tomita K. Expression analysis for the identification of genes involved in acquired resistance to cisplatin in osteosarcoma cells. Cancer Genomics Proteomics. 2006;3:373–82.
CAS
Google Scholar
Hegde R, Thimmaiah P, Yerigeri MC, Krishnegowda G, Thimmaiah KN, Houghton PJ. Anti-calmodulin acridone derivatives modulate vinblastine resistance in multidrug resistant (MDR) cancer cells. Eur J Med Chem. 2004;39:161–77.
Article
CAS
PubMed
Google Scholar
Ménard S, Castronovo V, Tagliabue E, Sobel ME. New insights into the metastasis-associated 67 kD laminin receptor. J Cell Biochem. 1997;67:155–65.
Article
PubMed
Google Scholar
Cioce V, Castronovo V, Shmookler BM, Garbisa S, Grigioni WF, Liotta LA, et al. Increased Expression of the Laminin Receptor in Human Colon Cancer. J Natl Cancer Inst. 1991;83:29–36.
Article
CAS
PubMed
Google Scholar
Castronovo V, Campo E, Brûle FA, Claysmith AP, Cioce V, Liu F-T, et al. Inverse Modulation of Steady-State Messenger RNA Levels of Two Non-Integrin Laminin-Binding Proteins in Human Colon Carcinoma. J Natl Cancer Inst. 1992;84:1161–9.
Article
CAS
PubMed
Google Scholar
Carbone A, Gloghini A, Colombatti A, Castronovo V, Menard S. Expression of the monomeric 67-kd laminin-binding protein in human lymphomas as defined by MLuC5 monoclonal antibody and paraffin section immunohistochemistry. Hum Pathol. 1995;26:541–6.
Article
CAS
PubMed
Google Scholar
Vacca A, Ribatti D, Roncali L, Lospalluti M, Serio G, Carrel S, et al. Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67-kilodalton laminin receptor. Cancer. 1993;72:455–61.
Article
CAS
PubMed
Google Scholar
Perrin BJ, Ervasti JM. The actin gene family: function follows isoform. Cytoskeleton. 2010;67:630–4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chi SL, Pizzo SV. Cell surface F1Fo ATP synthase: A new paradigm? Ann Med. 2006;38:429–38.
Article
CAS
PubMed
Google Scholar
Juan HF, Chang HY, Huang TC, Hsu CH, Kuo WH, Chang KJ. Method of treating cancer using ATP synthase inhibitors. US patent no. 514456 National Taiwan University. 2010.
Google Scholar
Hoffrogge R, Beyer S, Hübner R, Mikkat S, Mix E, Scharf C, et al. 2-DE profiling of GDNF overexpression-related proteome changes in differentiating ST14A rat progenitor cells. Proteomics. 2007;7:33–46.
Article
CAS
PubMed
Google Scholar
Warburg O. The Metabolism of Tumours: Investigations from the Kaiser Wilhelm Institute for Biology. Br J Surg. 1930;19:168.
Google Scholar
Lee HC, Yin PH, Lin JC, Wu CC, Chen CY, Wu CW, et al. Mitochondrial Genome Instability and mtDNA Depletion in Human Cancers. Ann N Y Acad Sci. 2005;1042:109–22.
Article
CAS
PubMed
Google Scholar
Young C, Anderson S. Sugar and fat - that’s where it’s at: metabolic changes in tumors. Breast Cancer Res. 2008;10:202.
Article
PubMed
PubMed Central
CAS
Google Scholar
Michalak M, Milner RE, Burns K, Opas M. Calreticulin. Biochem J. 1992;285:681–92.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhu N, Pewitt EB, Cai X, Cohn EB, Lang S, Chen R, et al. Calreticulin: An Intracellular Ca++ − Binding Protein Abundantly Expressed and Regulated by Androgen in Prostatic Epithelial Cells. Endocrinology. 1998;139:4337–44.
Article
CAS
PubMed
Google Scholar
Liu N, Fine RE, Simons E, Johnson RJ. Decreasing calreticulin expression lowers the Ca2+ response to bradykinin and increases sensitivity to ionomycin in NG-108-15 cells. J Biol Chem. 1994;269:28635–9.
CAS
PubMed
Google Scholar
Nakajo S, Okamoto M, Masuda Y, Sakai I, Ohsawa S, Nakaya K. Geranylgeraniol Causes a Decrease in Levels of Calreticulin and Tyrosine Phosphorylation of a 36-kDa Protein Prior to the Appearance of Apoptotic Features in HL-60 Cells. Biochem Biophys Res Commun. 1996;226:741–5.
Article
CAS
PubMed
Google Scholar
Chao MP, Jaiswal S, Weissman-Tsukamoto R, Alizadeh AA, Gentles AJ, Volkmer J, et al. Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47. Sci Transl Med. 2010;2:63ra94.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wu M, Bai X, Xu G, Wei J, Zhu T, Zhang Y, et al. Proteome analysis of human androgen-independent prostate cancer cell lines: Variable metastatic potentials correlated with vimentin expression. Proteomics. 2007;7:1973–83.
Article
CAS
PubMed
Google Scholar
Takemura K, Hirayama R, Hirokawa K, Inagaki M, Tsujimura K, Esaki Y, et al. Expression of Vimentin in Gastric Cancer: A Possible Indicator for Prognosis. Pathobiology. 1994;62:149–54.
Article
CAS
PubMed
Google Scholar
Jin H, Morohashi S, Sato F, Kudo Y, Akasaka H, Tsutsumi S, et al. Vimentin expression of esophageal squamous cell carcinoma and its aggressive potential for lymph node metastasis. Biomed Res. 2010;31:105–12.
Article
CAS
PubMed
Google Scholar
Gilles C, Polette M, Mestdagt M, Nawrocki-Raby B, Ruggeri P, Birembaut P, et al. Transactivation of Vimentin by β-Catenin in Human Breast Cancer Cells. Cancer Res. 2003;63:2658–64.
CAS
PubMed
Google Scholar
Satelli A, Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci. 2011;68:3033–46.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mcinroy L, Määttä A. Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion. Biochem Biophys Res Commun. 2007;360:109–14.
Article
CAS
PubMed
Google Scholar
Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2:442–54.
Article
CAS
PubMed
Google Scholar
Herrmann PC, Gillespie JW, Charboneau L, Bichsel VE, Paweletz CP, Calvert VS, et al. Mitochondrial proteome: Altered cytochrome c oxidase subunit levels in prostate cancer. Proteomics. 2003;3:1801–10.
Article
CAS
PubMed
Google Scholar
De LC-HE, Perez-Plasencia C, Perez-Cardenas E, Gonzalez-Fierro A, Trejo-Becerril C, Chavez-Blanco A, et al. Transcriptional changes induced by epigenetic therapy with hydralazine and magnesium valproate in cervical carcinoma. Oncol Rep. 2011;25:399–407.
Google Scholar
Yusenko MV, Ruppert T, Kovacs G. Analysis of differentially expressed mitochondrial proteins in chromophobe renal cell carcinomas and renal oncocytomas by 2-D gel electrophoresis. Int J Biol Sci. 2010;6:213–24.
Article
CAS
PubMed
PubMed Central
Google Scholar
inventor. Identification of cytochrome oxidase COX4-2 as an early lung cancer diagnostic biomarker. Patent no. US patent classification. 2006.
Google Scholar
Chen WL, Kuo KT, Chou TY, Chen CL, Wang CH, Wei YH, et al. The role of cytochrome c oxidase subunit Va in non-small cell lung carcinoma cells: association with migration, invasion and prediction of distant metastasis. BMC Cancer. 2012;12:273.
Article
CAS
PubMed
PubMed Central
Google Scholar
Telang S, Nelson K, Siow D, Yalcin A, Thornburg J, Imbert-Fernandez Y, et al. Cytochrome c oxidase is activated by the oncoprotein Ras and is required for A549 lung adenocarcinoma growth. Mol Cancer. 2012;11:60.
Article
CAS
PubMed
PubMed Central
Google Scholar
Baris O, Savagner F, Nasser V, Loriod B, Granjeaud S, Guyetant S, et al. Transcriptional Profiling Reveals Coordinated Up-Regulation of Oxidative Metabolism Genes in Thyroid Oncocytic Tumors. J Clin Endocrinol Metab. 2004;89:994–1005.
Article
CAS
PubMed
Google Scholar
Wang Y, Kuramitsu Y, Ueno T, Suzuki N, Yoshino S, Iizuka N, et al. Differential expression of up-regulated cofilin-1 and down-regulated cofilin-2 characteristic of pancreatic cancer tissues. Oncol Rep. 2011;26:1595–9.
CAS
PubMed
Google Scholar
Zhu B, Fukada K, Zhu H, Kyprianou N. Prohibitin and cofilin are intracellular effectors of transforming growth factor β signaling in human prostate cancer cells. Cancer Res. 2006;66:8640–7.
Article
CAS
PubMed
Google Scholar
Song Y, Yang Z, Ke Z, Yao Y, Hu X, Sun Y, et al. Expression of 14-3-3γ in patients with breast cancer: Correlation with clinicopathological features and prognosis. Cancer Epidemiol. 2012;36:533–6.
Article
CAS
PubMed
Google Scholar
Ladd JJ, Busald T, Johnson MM, Zhang Q, Pitteri SJ, Wang H, et al. Increased Plasma Levels of the APC-Interacting Protein MAPRE1, LRG1, and IGFBP2 Preceding a Diagnosis of Colorectal Cancer in Women. Cancer Prev Res (Phila Pa). 2012;5:655–64.
Article
CAS
Google Scholar
Fujii K, Kondo T, Yokoo H, Yamada T, Iwatsuki K, Hirohashi S. Proteomic study of human hepatocellular carcinoma using two-dimensional difference gel electrophoresis with saturation cysteine dye. Proteomics. 2005;5:1411–22.
Article
CAS
PubMed
Google Scholar
Kim K, Lee H-C, Park J-L, Kim M, Kim S-Y, Noh S-M, et al. Epigenetic regulation of microRNA-10b and targeting of oncogenic MAPRE1 in gastric cancer. Epigenetics. 2011;6:740–51.
Article
CAS
PubMed
Google Scholar
Wang Y, Zhou X, Zhu H, Liu S, Zhou C, Zhang G, et al. Overexpression of EB1 in human esophageal squamous cell carcinoma (ESCC) may promote cellular growth by activating β-catenin/TCF pathway. Oncogene. 2005;24:6637–45.
Article
CAS
PubMed
Google Scholar
Tsui KH, Cheng AJ, Chang PL, Pan TL, Yung BYM. Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma. Urology. 2004;64:839–44.
Article
PubMed
Google Scholar
Skaar TC, Prasad SC, Sharareh S, Lippman ME, Brünner N, Clarke R. Two-dimensional gel electrophoresis analyses identify nucleophosmin as an estrogen regulated protein associated with acquired estrogen-independence in human breast cancer cells. J Steroid Biochem Mol Biol. 1998;67:391–402.
Article
CAS
PubMed
Google Scholar
Nozawa Y, Van Belzen N, Van Der Made ACJ, Dinjens WNM, Bosman FT. Expression of Nucleophosmin/B23 in Normal and Neoplastic Colorectal Mucosa. J Pathol. 1996;178:48–52.
Article
CAS
PubMed
Google Scholar
Tanaka M, Sasaki H, Kino I, Sugimura T, Terada M. Genes Preferentially Expressed in Embryo Stomach are Predominantly Expressed in Gastric Cancer. Cancer Res. 1992;52:3372–7.
CAS
PubMed
Google Scholar
Shields LB, Gerçel-Taylor C, Yashar CM, Wan TC, Katsanis WA, Spinnato JA, et al. Induction of immune responses to ovarian tumor antigens by multiparity. J Soc Gynecol Investig. 1997;4:298–304.
Article
CAS
PubMed
Google Scholar
Subong ENP, Shue MJ, Epstein JI, Briggman JV, Chan PK, Partin AW. Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4–216) recognizes nucleophosmin/B23. Prostate. 1999;39:298–304.
Article
CAS
PubMed
Google Scholar
Ahn SH, Sawada H, Ro JY, Nicolson GL. Differential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissues. Clin Exp Metastasis. 1997;15:151–6.
Article
CAS
PubMed
Google Scholar
Yu G, Wang J, Chen Y, Wang X, Pan J, Li Q, et al. Tissue microarray analysis reveals strong clinical evidence for a close association between loss of annexin A1 expression and nodal metastasis in gastric cancer. Clin Exp Metastasis. 2008;25:695–702.
Article
CAS
PubMed
Google Scholar
Masaki T, Tokuda M, Ohnishi M, Watanabe S, Fujimura T, Miyamoto K, et al. Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinoma. Hepatology. 1996;24:72–81.
CAS
PubMed
Google Scholar
Paweletz CP, Ornstein DK, Roth MJ, Bichsel VE, Gillespie JW, Calvert VS, et al. Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res. 2000;60:6293–7.
CAS
PubMed
Google Scholar
Xia SH, Hu LP, Hu H, Ying WT, Xu X, Cai Y, et al. Three isoforms of annexin I are preferentially expressed in normal esophageal epithelia but down-regulated in esophageal squamous cell carcinomas. Oncogene. 2002;21:6641–8.
Article
CAS
PubMed
Google Scholar
Kang JS, Calvo BF, Maygarden SJ, Caskey LS, Mohler JL, Ornstein DK. Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. Clin Cancer Res. 2002;8:117–23.
CAS
PubMed
Google Scholar
Viacava P, Naccarato AG, Collecchi P, Ménard S, Castronovo V, Bevilacqua G. The Spectrum 67-kD Laminin Receptor Expression in Breast Carcinoma Progression. J Pathol. 1997;182:36–44.
Article
CAS
PubMed
Google Scholar
Al-Saleh W, Delvenne P, Van Den Brule FA, Menard S, Boniver J, Castronovo V. Expression of the 67 kD laminin receptor in human cervical preneoplastic and neoplastic squamous epithelial lesions: an immunohistochemical study. J Pathol. 1997;181:287–93.
Article
CAS
PubMed
Google Scholar
Sanjuán X, Fernández PL, Miquel R, Muñoz J, Castronovo V, Ménard S, et al. Overexpression of the 67-kD Laminin Receptor Correlates with Tumour Progression in Human Colorectal Carcinoma. J Pathol. 1996;179:376–80.
Article
PubMed
Google Scholar
Kumazoe M, Sugihara K, Tsukamoto S, Huang Y, Tsurudome Y, Suzuki T, et al. 67-kDa laminin receptor increases cGMP to induce cancer-selective apoptosis. J Clin Invest. 2013;123:787–99.
CAS
PubMed
PubMed Central
Google Scholar
Nowak D, Skwarek-Maruszewska A, Zemanek-Zboch M, Malicka-Blaszkiewicz M. Beta-actin in human colon adenocarcinoma cell lines with different metastatic potential. Acta Biochim Pol. 2005;52:461–8.
CAS
PubMed
Google Scholar
Xu J, Zhang Z, Chen J, Liu F, Bai L. Overexpression of β-actin is closely associated with metastasis of gastric cancer. Hepatogastroenterology. 2013;60:620–3.
CAS
PubMed
Google Scholar
Popow A, Nowak D, Malicka-Blaszkiewicz M. Actin cytoskeleton and beta-actin expression in correlation with higher invasiveness of selected hepatoma Morris 5123 cells. J Physiol Pharmacol. 2006;57 Suppl 7:111–23.
PubMed
Google Scholar
Le PU, Nguyen TN, Drolet-Savoie P, Leclerc N, Nabi IR. Increased β-Actin Expression in an Invasive Moloney Sarcoma Virus-transformed MDCK Cell Variant Concentrates to the Tips of Multiple Pseudopodia. Cancer Res. 1998;58:1631–5.
CAS
PubMed
Google Scholar
Volmer MW, Stühler K, Zapatka M, Schöneck A, Klein-Scory S, Schmiegel W, et al. Differential proteome analysis of conditioned media to detect Smad4 regulated secreted biomarkers in colon cancer. Proteomics. 2005;5:2587–601.
Article
CAS
PubMed
Google Scholar
Kim B, Bang S, Lee S, Kim S, Jung Y, Lee C, et al. Expression Profiling and Subtype-Specific Expression of Stomach Cancer. Cancer Res. 2003;63:8248–55.
CAS
PubMed
Google Scholar
Zhang R, Tremblay T-L, McDermid A, Thibault P, Stanimirovic D. Identification of differentially expressed proteins in human glioblastoma cell lines and tumors. Glia. 2003;42:194–208.
Article
PubMed
Google Scholar
Deprimo SE, Diehn M, Nelson JB, Reiter RE, Matese J, Fero M, et al. Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol. 2002;3:1.
Article
Google Scholar
Yang Y-X, Sun X-F, Cheng A-L, Zhang G-Y, Yi H, Sun Y, et al. Increased expression of HSP27 linked to vincristine resistance in human gastric cancer cell line. J Cancer Res Clin Oncol. 2009;135:181–9.
Article
CAS
PubMed
Google Scholar
Pines A, Bivi N, Vascotto C, Romanello M, D’Ambrosio C, Scaloni A, et al. Nucleotide receptors stimulation by extracellular ATP controls Hsp90 expression through APE1/Ref-1 in thyroid cancer cells: A novel tumorigenic pathway. J Cell Physiol. 2006;209:44–55.
Article
CAS
PubMed
Google Scholar
Tu SH, Chang CC, Chen CS, Tam KW, Wang YJ, Lee CH, et al. Increased expression of enolase α in human breast cancer confers tamoxifen resistance in human breast cancer cells. Breast Cancer Res Treat. 2010;121:539–53.
Article
CAS
PubMed
Google Scholar
Chang GC, Liu KJ, Hsieh CL, Hu TS, Charoenfuprasert S, Liu HK, et al. Identification of α-Enolase as an Autoantigen in Lung Cancer: Its Overexpression Is Associated with Clinical Outcomes. Clin Cancer Res. 2006;12:5746–54.
Article
CAS
PubMed
Google Scholar
Cheng C, Long X, Li X, Xie M, Guo M. The expressions of alpha-enolase in the nasopharyngeal cancer tissue. J Clin otorhinolaryngol Head Neck Surg. 2011;25:554–6.
CAS
Google Scholar
Duffy MJ. Predictive Markers in Breast and Other Cancers: A Review. Clin Chem. 2005;51:494–503.
Article
CAS
PubMed
Google Scholar
Seth R, Keeley J, Abu-Ali G, Crook S, Jackson D, Ilyas M. The putative tumour modifier gene ATP5A1 is not mutated in human colorectal cancer cell lines but expression levels correlate with TP53 mutations and chromosomal instability. J Clin Pathol. 2009;62:598–603.
Article
CAS
PubMed
Google Scholar
Kim NS, Hahn Y, Oh JH, Lee JY, Oh KJ, Kim JM, et al. Gene cataloging and expression profiling in human gastric cancer cells by expressed sequence tags. Genomics. 2004;83:1024–45.
Article
PubMed
Google Scholar
Hofmann WK, de Vos S, Elashoff D, Gschaidmeier H, Hoelzer D, Koeffler HP, et al. Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression study. Lancet. 2002;359:481–6.
Article
CAS
PubMed
Google Scholar
Onda M, Emi M, Yoshida A, Miyamoto S, Akaishi J, Asaka S, et al. Comprehensive gene expression profiling of anaplastic thyroid cancers with cDNA microarray of 25 344 genes. Endocr Relat Cancer. 2004;11:843–54.
Article
CAS
PubMed
Google Scholar
Teramoto R, Minagawa H, Honda M, Miyazaki K, Tabuse Y, Kamijo K, et al. Protein expression profile characteristic to hepatocellular carcinoma revealed by 2D-DIGE with supervised learning. Biochim Biophys Acta Protein Proteomics. 2008;1784:764–72.
Article
CAS
Google Scholar
Chambery A, Farina A, Di Maro A, Rossi M, Abbondanza C, Moncharmont B, et al. Proteomic Analysis of MCF-7 Cell Lines Expressing the Zinc-Finger or the Proline-Rich Domain of Retinoblastoma-Interacting-Zinc-Finger Protein. J Proteome Res. 2006;5:1176–85.
Article
CAS
PubMed
Google Scholar
Nagai MA, da Rós N, Neto MM, de Faria Junior SR, Brentani MM, Hirata R, et al. Gene expression profiles in breast tumors regarding the presence or absence of estrogen and progesterone receptors. Int J Cancer. 2004;111:892–9.
Article
CAS
PubMed
Google Scholar
Kwong KY, Bloom GC, Yang I, Boulware D, Coppola D, Haseman J, et al. Synchronous global assessment of gene and protein expression in colorectal cancer progression. Genomics. 2005;86:142–58.
Article
CAS
PubMed
Google Scholar
Notari M, Neviani P, Santhanam R, Blaser BW, Chang J-S, Galietta A, et al. A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation. Blood. 2006;107:2507–16.
Article
CAS
PubMed
PubMed Central
Google Scholar
Perrotti D, Neviani P. From mRNA Metabolism to Cancer Therapy: Chronic Myelogenous Leukemia Shows the Way. Clin Cancer Res. 2007;13:1638–42.
Article
CAS
PubMed
Google Scholar
Keenan J, Murphy L, Henry M, Meleady P, Clynes M. Proteomic analysis of multidrug-resistance mechanisms in adriamycin-resistant variants of DLKP, a squamous lung cancer cell line. Proteomics. 2009;9:1556–66.
Article
CAS
PubMed
Google Scholar
Lohavanichbutr P, Houck J, Fan W, et al. Genomewide gene expression profiles of hpv-positive and hpv-negative oropharyngeal cancer: Potential implications for treatment choices. Arch Otolaryngol Head Neck Surg. 2009;135:180–8.
Article
PubMed
PubMed Central
Google Scholar
Alldinger I, Dittert D, Peiper M, Fusco A, Chiappetta G, Staub E, et al. Gene expression analysis of pancreatic cell lines reveals genes overexpressed in pancreatic cancer. Pancreatology. 2005;5:370–9.
Article
CAS
PubMed
Google Scholar
Cappello F, Di Stefano A, David S, Rappa F, Anzalone R, La Rocca G, et al. Hsp60 and Hsp10 down-regulation predicts bronchial epithelial carcinogenesis in smokers with chronic obstructive pulmonary disease. Cancer. 2006;107:2417–24.
Article
CAS
PubMed
Google Scholar
Cappello F, David S, Rappa F, Bucchieri F, Marasa L, Bartolotta T, et al. The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase. BMC Cancer. 2005;5:139.
Article
PubMed
PubMed Central
CAS
Google Scholar
Thomas X, Campos L, Mounier C, Cornillon J, Flandrin P, Le Q-H, et al. Expression of heat-shock proteins is associated with major adverse prognostic factors in acute myeloid leukemia. Leuk Res. 2005;29:1049–58.
Article
CAS
PubMed
Google Scholar
Tang D, Abdul Khaleque MD, Jones EL, Theriault JR, Li C, Wong WH, et al. Expression of heat shock proteins and heat shock protein messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo. Cell Stress Chaperones. 2005;10:46–58.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bauer KM, Lambert PA, Hummon AB. Comparative label-free LC-MS/MS analysis of colorectal adenocarcinoma and metastatic cells treated with 5-fluorouracil. Proteomics. 2012;12:1928–37.
Article
CAS
PubMed
PubMed Central
Google Scholar
Farooq M, Hozzein WN, Elsayed EA, Taha NA, Wadaan MAM. Identification of Histone Deacetylase 1 Protein Complexes in Liver Cancer Cells. Asian Pac J Cancer Prev. 2013;14:915–21.
Article
PubMed
Google Scholar
Wadhwa R, Takano S, Kaur K, Deocaris CC, Pereira-Smith OM, Reddel RR, et al. Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesis. Int J Cancer. 2006;118:2973–80.
Article
CAS
PubMed
Google Scholar
Petrova DT, Asif AR, Armstrong VW, Dimova I, Toshev S, Yaramov N, et al. Expression of chloride intracellular channel protein 1 (CLIC1) and tumor protein D52 (TPD52) as potential biomarkers for colorectal cancer. Clin Biochem. 2008;41:1224–36.
Article
CAS
PubMed
Google Scholar
Suehara Y, Kikuta K, Nakayama R, Tochigi N, Seki K, Ichikawa H, et al. GST-P1 as a histological biomarker of synovial sarcoma revealed by proteomics. PROTEOMICS – Clinical Applications. 2009;3:623–34.
Article
CAS
Google Scholar
Pucci-Minafra I, Cancemi P, Albanese NN, Di Cara G, Marabeti MR, Marrazzo A, et al. New Protein Clustering of Breast Cancer Tissue Proteomics Using Actin Content as a Cellularity Indicator. J Proteome Res. 2008;7:1412–8.
Article
CAS
PubMed
Google Scholar
Semaan SM, Wang X, Stewart PA, Marshall AG, Sang Q-XA. Differential phosphopeptide expression in a benign breast tissue, and triple-negative primary and metastatic breast cancer tissues from the same African-American woman by LC-LTQ/FT-ICR mass spectrometry. Biochem Biophys Res Commun. 2011;412:127–31.
Article
CAS
PubMed
Google Scholar
Michael MZ, O’ Connor SM, Van Holst Pellekaan NG, Young GP, James RJ. Reduced Accumulation of Specific MicroRNAs in Colorectal Neoplasia. Mol Cancer Res. 2003;1:882–91.
CAS
PubMed
Google Scholar
Li C, Tan YX, Zhou H, Ding SJ, Li SJ, Ma D, et al. Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: Identification of potential tumor markers. Proteomics. 2005;5:1125–39.
Article
PubMed
CAS
Google Scholar
Stephenson AJ, Smith A, Kattan MW, Satagopan J, Reuter VE, Scardino PT, et al. Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy. Cancer. 2005;104:290–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Erić A, Juranić Z, Milovanović Z, Marković I, Inić M, Stanojević-Bakić N, et al. Effects of Humoral Immunity and Calreticulin Overexpression on Postoperative Course in Breast Cancer. Pathol Oncol Res. 2009;15:89–90.
Article
PubMed
CAS
Google Scholar
Toquet C, Jarry A, Bou-Hanna C, Bach K, Denis MG, Mosnier JF, et al. Altered Calreticulin expression in human colon cancer: Maintenance of Calreticulin expression is associated with mucinous differentiation. Oncol Rep. 2007;17:1101–7.
CAS
PubMed
Google Scholar
Chen CN, Chang CC, Su TE, Hsu WM, Jeng YM, Ho MC, et al. Identification of Calreticulin as a Prognosis Marker and Angiogenic Regulator in Human Gastric Cancer. Ann Surg Oncol. 2009;16:524–33.
Article
CAS
PubMed
Google Scholar
Yoon GS, Lee H, Jung Y, Yu E, Moon HB, Song K, et al. Nuclear Matrix of Calreticulin in Hepatocellular Carcinoma. Cancer Res. 2000;60:1117–20.
CAS
PubMed
Google Scholar
Hong SH, Misek DE, Wang H, Puravs E, Giordano TJ, Greenson JK, et al. An Autoantibody-Mediated Immune Response to Calreticulin Isoforms in Pancreatic Cancer. Cancer Res. 2004;64:5504–10.
Article
CAS
PubMed
Google Scholar
Alaiya A, Roblick U, Egevad L, Carlsson A, Franzén B, Volz D, et al. Polypeptide expression in prostate hyperplasia and prostate adenocarcinoma. Anal Cell Pathol. 2000;21:1–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Thomas PA, Kirschmann DA, Cerhan JR, Folberg R, Seftor EA, Sellers TA, et al. Association between Keratin and Vimentin Expression, Malignant Phenotype, and Survival in Postmenopausal Breast Cancer Patients. Clin Cancer Res. 1999;5:2698–703.
CAS
PubMed
Google Scholar
Fuyuhiro Y, Yashiro M, Noda S, Kashiwagi S, Matsuoka J, Doi Y, et al. Clinical Significance of Vimentin-positive Gastric Cancer Cells. Anticancer Res. 2010;30:5239–43.
PubMed
Google Scholar
Dauphin M, Barbe C, Lemaire S, Nawrocki-Raby B, Lagonotte E, Delepine G, et al. Vimentin expression predicts the occurrence of metastases in non small cell lung carcinomas. Lung Cancer. 2013;81:117–22.
Article
PubMed
Google Scholar
Handra-Luca A, Hong SM, Walter K, Wolfgang C, Hruban R, Goggins M. Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas. Br J Cancer. 2011;104:1296–302.
Article
CAS
PubMed
PubMed Central
Google Scholar